I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Cegla, J.
276
results:
Articles (Online) X
Search for persons
X
Languages
english (206)
german (35)
Sorted by: Relevance
Sorted by: Year
?
1
Lomitapide hepatic safety: A long-term retrospective analys..:
Cegla, J.
;
Larrey, D.
;
D'Erasmo, L.
..
Atherosclerosis Plus. 54 (2023) - p. S2-S3 , 2023
Link:
https://doi.org/10.1016/..
?
2
Cardiovascular disease morbidity is associated with social ..:
Iyen, B.
;
Qureshi, N.
;
Roderick, P.
...
Atherosclerosis Plus. 49 (2022) - p. S4-S5 , 2022
Link:
https://doi.org/10.1016/..
?
3
Lomitapide in the long-term real-world management of HoFH –..:
Cegla, J.
;
d'Erasmo, L.
;
Steward, K.
...
Atherosclerosis Plus. 49 (2022) - p. S2-S3 , 2022
Link:
https://doi.org/10.1016/..
?
4
Lipoprotein (a) – Current status in the UK:
Ansari, S.
;
Neely, D.
;
Payne, J.
.
Atherosclerosis Plus. 49 (2022) - p. S2 , 2022
Link:
https://doi.org/10.1016/..
?
5
Lipoprotein apheresis reduces SARS-CoV-2 S protein antibody..:
Valaiyapathi, R.
;
Barton, L.
;
Carvalho, L.
...
Atherosclerosis Plus. 49 (2022) - p. S3-S4 , 2022
Link:
https://doi.org/10.1016/..
?
6
The effect of adjusting LDL-cholesterol for Lipoprotein(a)-..:
Thayabaran, D.
;
Tsui, A.P.T.
;
Ebmeier, S.J.
...
Atherosclerosis Plus. 49 (2022) - p. S3 , 2022
Link:
https://doi.org/10.1016/..
?
7
Absence of coronary artery calcium does not exclude coronar..:
Israni, A.
;
Hart, T.
;
Cegla, J.
.
Atherosclerosis Plus. 43 (2021) - p. S7 , 2021
Link:
https://doi.org/10.1016/..
?
8
Inpatient management of severe hypertriglyceridaemia at a t..:
Yang, W.
;
Misra, S.
;
Cegla, J.
.
Atherosclerosis Plus. 43 (2021) - p. S9 , 2021
Link:
https://doi.org/10.1016/..
?
9
Reduction in cardiovascular disease morbidity of men and wo..:
Iyen, B.
;
Qureshi, N.
;
Roderick, P.
...
Atherosclerosis Plus. 43 (2021) - p. S5 , 2021
Link:
https://doi.org/10.1016/..
?
10
APOE gene testing in FH referrals – the story so far:
Duff-Farrier, C.
;
Pennock, M.
;
Watson, E.
...
Atherosclerosis Plus. 43 (2021) - p. S2 , 2021
Link:
https://doi.org/10.1016/..
?
11
Lipoprotein(a) as a biomarker for subclinical coronary and ..:
Low, B.
;
Trivedi, N.
;
Loh, W.J.
..
Atherosclerosis. 331 (2021) - p. e113-e114 , 2021
Link:
https://doi.org/10.1016/..
?
12
Statin treatment reduces plasma FGF19 in healthy volunteers..:
Haqiqi, A.
;
Cegla, J.
;
Jones, B.
Atherosclerosis. 315 (2020) - p. e153-e154 , 2020
Link:
https://doi.org/10.1016/..
?
13
Evolocumab therapy and a possible association with skin rea..:
Ragavan, A.
;
David, A.
;
Scott, J.
..
Atherosclerosis Supplements. 38 (2019) - p. e7 , 2019
Link:
https://doi.org/10.1016/..
?
14
Coronary Calcium Score In Patients With Clinical Criteria F..:
David, A.
;
Hart, T.
;
Cegla, J.
...
Atherosclerosis Supplements. 38 (2019) - p. e2 , 2019
Link:
https://doi.org/10.1016/..
?
15
Three years experience of lomitapide therapy in the uk:
Cegla, J.
;
Walji, S.
;
Neuwirth, C.
...
Atherosclerosis Supplements. 38 (2019) - p. e6-e7 , 2019
Link:
https://doi.org/10.1016/..
1-15